Clinical response in patients with ovarian cancer treated with

• DOI: 10.3332/ecancer.2017.723
• Publication Date: 2017-02-28T14:09:34Z
• Authors: Herman Andrés Per...; O Graciela Scharo...; Viviana Rosa Rozados; Carlos María Alasino
• Keywords: Short Communication; METRONOMIC CHEMOTHERAPY; OVARIAN CANCER; 3. Good health; 03 medical and health sciences; ovarian cancer; 0302 clinical medicine; https://purl.org/becyt/ford/1.6; CYCLOPHOSPHAMIDE; metronomic chemotherapy; cyclophosphamide; https://purl.org/becyt/ford/1

Ovarian cancer (OC) is the leading cause of death from gynaecological cancer.It extremely hard to diagnose in early stages and around 70% patients present with advanced disease.Metronomic chemotherapy (MCT) described as chronic administration of, generally low, equally spaced, doses chemotherapeutic drugs therapeutic efficacy low toxicity.This an effective low-cost way treat several types tumours, including ovarian cancer.Here, we six cases treated MCT cyclophosphamide, which showed clinical response stable disease.